Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study

DSpace Repository

Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study

Author: Guidet, Bertrand; Martinet, Olivier; Boulain, Thierry; Philippart, Francois; Poussel, Jean Francois; Maizel, Julien; Forceville, Xavier; Feissel, Marc; Hasselmann, Michel; Heininger, Alexandra; Van Aken, Hugo
Tübinger Autor(en):
Heininger, Alexandra
Published in: Critical Care (2012), Bd. 16, Article R94
Verlagsangabe: Biomed Central Ltd
Language: English
Full text: http://dx.doi.org/10.1186/cc11358
ISSN: 1466-609X
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)